Get started
LANTHEUS HOLDINGS INCLANTHEUS HOLDINGS INCLANTHEUS HOLDINGS INC

LANTHEUS HOLDINGS INC

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast Bonds

0L8 chart


Full chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.71 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
17.51
Basic EPS (TTM)
5.82EUR
Net income (FY)
‪295.96 M‬EUR
Revenue (FY)
‪1.17 B‬EUR
Shares float
‪67.67 M‬
Beta (1Y)
0.55

About Lantheus Holdings, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Brian A. Markison
Website
lantheus.com
Headquarters
Bedford
Employees (FY)
834
Founded
1956
FIGI
BBG006WYNDH4
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

News



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Highest yielding bonds


HRG5717197
Lantheus Holdings, Inc. 2.625% 15-DEC-2027

Explore more bonds 

Frequently Asked Questions


The current price of 0L8 is 94.52 EUR — it has decreased by −0.82% in the past 24 hours. Watch LANTHEUS HOLDINGS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange LANTHEUS HOLDINGS INC stocks are traded under the ticker 0L8.
0L8 stock has risen by 6.78% compared to the previous week, the month change is a 10.94% rise, over the last year LANTHEUS HOLDINGS INC has showed a 57.85% increase.
We've gathered analysts' opinions on LANTHEUS HOLDINGS INC future price: according to them, 0L8 price has a max estimate of 158.48 EUR and a min estimate of 113.20 EUR. Watch 0L8 chart and read a more detailed LANTHEUS HOLDINGS INC stock forecast: see what analysts think of LANTHEUS HOLDINGS INC and suggest that you do with its stocks.
0L8 reached its all-time high on Jul 12, 2024 with the price of 115.30 EUR, and its all-time low was 1.61 EUR and was reached on Feb 11, 2016. View more price dynamics on 0L8 chart.
See other stocks reaching their highest and lowest prices.
0L8 stock is 1.10% volatile and has beta coefficient of 0.55. Track LANTHEUS HOLDINGS INC stock price on the chart and check out the list of the most volatile stocks — is LANTHEUS HOLDINGS INC there?
Today LANTHEUS HOLDINGS INC has the market capitalization of ‪6.72 B‬, it has decreased by −1.61% over the last week.
Yes, you can track LANTHEUS HOLDINGS INC financials in yearly and quarterly reports right on TradingView.
LANTHEUS HOLDINGS INC is going to release the next earnings report on Oct 31, 2024. Keep track of upcoming events with our Earnings Calendar.
0L8 earnings for the last quarter are 1.68 EUR per share, whereas the estimation was 1.71 EUR resulting in a −1.62% surprise. The estimated earnings for the next quarter are 1.40 EUR per share. See more details about LANTHEUS HOLDINGS INC earnings.
LANTHEUS HOLDINGS INC revenue for the last quarter amounts to ‪367.92 M‬ EUR, despite the estimated figure of ‪356.75 M‬ EUR. In the next quarter, revenue is expected to reach ‪334.52 M‬ EUR.
0L8 net income for the last quarter is ‪57.95 M‬ EUR, while the quarter before that showed ‪121.47 M‬ EUR of net income which accounts for −52.29% change. Track more LANTHEUS HOLDINGS INC financial stats to get the full picture.
No, 0L8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 18, 2024, the company has 834.00 employees. See our rating of the largest employees — is LANTHEUS HOLDINGS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LANTHEUS HOLDINGS INC EBITDA is ‪478.46 M‬ EUR, and current EBITDA margin is 42.69%. See more stats in LANTHEUS HOLDINGS INC financial statements.
Like other stocks, 0L8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LANTHEUS HOLDINGS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LANTHEUS HOLDINGS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LANTHEUS HOLDINGS INC stock shows the buy signal. See more of LANTHEUS HOLDINGS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.